Aurobindo Pharma Q2 PAT seen up 11.1% YoY to Rs. 672.7 cr: Kotak

Net Sales are expected to increase by 6.9 percent Y-o-Y (up 9.7 percent Q-o-Q) to Rs. 4035.4 crore, according to Kotak.